BMRN
Price
$57.99
Change
+$0.58 (+1.01%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
11.12B
27 days until earnings call
FOLD
Price
$6.22
Change
+$0.17 (+2.81%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
1.92B
22 days until earnings call
Interact to see
Advertisement

BMRN vs FOLD

Header iconBMRN vs FOLD Comparison
Open Charts BMRN vs FOLDBanner chart's image
BioMarin Pharmaceutical
Price$57.99
Change+$0.58 (+1.01%)
Volume$52.23K
Capitalization11.12B
Amicus Therapeutics
Price$6.22
Change+$0.17 (+2.81%)
Volume$79.53K
Capitalization1.92B
BMRN vs FOLD Comparison Chart in %
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. FOLD commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and FOLD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (BMRN: $57.99 vs. FOLD: $6.22)
Brand notoriety: BMRN and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 114% vs. FOLD: 83%
Market capitalization -- BMRN: $11.12B vs. FOLD: $1.92B
BMRN [@Biotechnology] is valued at $11.12B. FOLD’s [@Biotechnology] market capitalization is $1.92B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, BMRN is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while FOLD’s TA Score has 4 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 3 bearish.
  • FOLD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than FOLD.

Price Growth

BMRN (@Biotechnology) experienced а +3.20% price change this week, while FOLD (@Biotechnology) price change was +6.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

BMRN is expected to report earnings on Oct 22, 2025.

FOLD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($11.1B) has a higher market cap than FOLD($1.92B). BMRN YTD gains are higher at: -11.775 vs. FOLD (-33.970). BMRN has higher annual earnings (EBITDA): 777M vs. FOLD (53.6M). BMRN has more cash in the bank: 1.27B vs. FOLD (251M). FOLD has less debt than BMRN: FOLD (443M) vs BMRN (602M). BMRN has higher revenues than FOLD: BMRN (2.95B) vs FOLD (543M).
BMRNFOLDBMRN / FOLD
Capitalization11.1B1.92B580%
EBITDA777M53.6M1,450%
Gain YTD-11.775-33.97035%
P/E Ratio21.48N/A-
Revenue2.95B543M543%
Total Cash1.27B251M507%
Total Debt602M443M136%
FUNDAMENTALS RATINGS
BMRN vs FOLD: Fundamental Ratings
BMRN
FOLD
OUTLOOK RATING
1..100
1414
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7093
PRICE GROWTH RATING
1..100
6384
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (63) in the Biotechnology industry is in the same range as FOLD (64). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FOLD (100). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's SMR Rating (70) in the Biotechnology industry is in the same range as FOLD (93). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's Price Growth Rating (63) in the Biotechnology industry is in the same range as FOLD (84). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's P/E Growth Rating (99) in the Biotechnology industry is in the same range as FOLD (100). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNFOLD
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 6 days ago
58%
Bullish Trend 6 days ago
69%
Declines
ODDS (%)
Bearish Trend 13 days ago
63%
Bearish Trend 21 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLUEX12.170.04
+0.33%
Lazard US Equity Concentrated R6
FMXKX7.90N/A
N/A
Federated Hermes Max-Cap Index R
SPQAX14.85N/A
N/A
PGIM Jennison Global Equity Income A
DGYGX40.03N/A
N/A
BNY Mellon Appreciation Y
FTHFX46.39N/A
N/A
FullerThaler Behavioral Sm-Cp Eq R6

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+1.01%
ITOS - BMRN
50%
Loosely correlated
+0.50%
SRPT - BMRN
45%
Loosely correlated
+9.87%
IBO - BMRN
42%
Loosely correlated
-4.62%
IONS - BMRN
42%
Loosely correlated
-1.05%
AXON - BMRN
42%
Loosely correlated
-1.49%
More